Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
CNS Spectrums|November 20, 2024
Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-AnalysisAngela T H Kwan, Moiz Lakhani, Gurkaran Singh, et al.
The Journal of Clinical Psychiatry|July 10, 2025
A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBaseAngela T H Kwan, Moiz Lakhani, Joshua D Rosenblat, et al.
Journal of Affective Disorders|January 16, 2025
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysisAngela T H Kwan, Moiz Lakhani, Kayla M Teopiz, et al.
JACC. Advances|March 21, 2025
Lipoprotein (a) Distribution in Aortic Stenosis Patients: Are Lp(a) Reducing Agents the Ultimate Solution?Michael-Roy R Durr, Ian G Burwash, Lawrence Lau, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
CNS Spectrums|May 26, 2025
Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implicationsKayla M Teopiz, Heidi K Y Lo, Moiz Lakhani, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 27, 2024
Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
American Journal of Ophthalmology|May 18, 2025
Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 CountriesMoiz Lakhani, Angela T H Kwan, Andrew Mihalache, et al.
Ophthalmology. Retina|November 6, 2025
Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 CountriesMoiz Lakhani, Marko M Popovic, Abdullah Al-Ani, et al.
Pageof 2